1
项与 Regulator T Cells(Xuzhou Medical University) 相关的临床试验Safety and Efficacy of Treg Cell in the Treatment of GVHD After Allogeneic Hematopoietic Stem Cell Transplantation
This is a randomized, single-center phase 1/2a clinical trial without blinding. Regulatory T cells (Tregs) have shown potential in treating various immune-related diseases, including autoimmune disorders, transplant rejection, and inflammatory diseases. The investigators plan to recruit participants for a clinical trial to evaluate the efficacy and safety of autologous Tregs in the treatment of GVHD.
100 项与 Regulator T Cells(Xuzhou Medical University) 相关的临床结果
100 项与 Regulator T Cells(Xuzhou Medical University) 相关的转化医学
100 项与 Regulator T Cells(Xuzhou Medical University) 相关的专利(医药)
100 项与 Regulator T Cells(Xuzhou Medical University) 相关的药物交易